A systematic review on multiparametric MR imaging in prostate cancer detection

Overview of attention for article published in Infectious Agents and Cancer, October 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

policy: 2 policy sources

twitter: 2 X users

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 77 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Magnetic Resonance Imaging Screening for Prostate Cancer: Clinical Utility and Guidelines

Cited by Canadian Agency for Drugs and Technologies in Health on 17 Oct 2019

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Prostate cancer: diagnosis and management : D: Diagnosing and identifying clinically significant prostate cancer

Cited by National Institute for Health and Care Excellence on 03 May 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Prostate cancer: diagnosis and management : F: Identifying prostate cancer clinical progression in people with low- to intermediate-risk cancer

Cited by National Institute for Health and Care Excellence on 02 May 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.